Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 1:13–25
Alberola J, Tamarit A, Igual R, Navarro D (2000) Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection. J Clin Virol 2:113–122
Alcendor DJ, Charest AM, Zhu WQ, Vigil HE, Knobel SM (2012) Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflamm 9:95
Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557–561
Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215
Aronoff DM, Correa H, Rogers LM, Arav-Boger R, Alcendor DJ (2017) A Placental pericytes and cytomegalovirus infectivity: implications for HCMV placental pathology and congenital disease. Am J Reprod Immunol 2017:78
Attwell D, Mishra A, Hall CN, O’Farrell FM, Dalkara T (2016) What is a pericyte? J Cereb Blood Flow Metab 2:451–455
Balabanov R, Dore-Duffy P (1998) Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 6:637–644
Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 1:1–13
Barnes LL, Capuano AW, Aiello AE, Turner AD, Yolken RH, Torrey EF, Bennett DA (2015) Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis 2:230–237
Beam E, Dioverti V, Razonable RR (2014) Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities. Curr Infect Dis Rep 9:419
Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology 7:452–464
Berman N, Belmont HM (2017) Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem. Lupus 4:431–434
Birbrair A (2018) Pericyte biology: development, homeostasis, and disease. Adv Exp Med Biol 1109:1–3
Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM et al (2018) Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther 5:122
Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G, Hafner G, Ossendorf M, Steinhagen K, Meyer J (2001) Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 24:2915–2921
Boeckh M, Geballe AP (2011) Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Investig 121:1673–1680
Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93–99
Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817–823
Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ (2008) Infection-induced inflammatory response of adipocytes in vitro. Int J Obes 32:892–901
Brito AF, Pinney JW (2020) The evolution of protein domain repertoires: shedding light on the origins of the Herpesviridae family. Virus Evol 6(1):veaa001. https://doi.org/10.1093/ve/veaa001
Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA (2019) Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci 13:282
Cai W, Liu H, Zhao J, Chen LY, Chen J, Lu Z, Hu X (2017) Pericytes in brain injury and repair after ischemic stroke. Transl Stroke Res 2:107–121
Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q (2018) Role of blood-brain barrier in Alzheimer’s disease. J Alzheimers Dis 4:1223–1234
Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202–213
Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 1:99–126
Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, Pawelec G, Maier AB (2012) Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study. Immun Ageing 1:18
Chen SJ, Wang SC, Chen YC (2019) Antiviral agents as therapeutic strategies against cytomegalovirus infections. Viruses 12(1):23
Collins-McMillen D, Buehler J, Peppenelli M, Goodrum F (2018) Molecular determinants and the regulation of human cytomegalovirus latency and reactivation. Viruses 10(8):20. pii: E444
Colugnati FA, Staras SA, Dollard SC, Cannon MJ (2007) Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 7:71
Dias DO, Kim H, Holl D, Werne Solnestam B, Lundeberg J, Carlén M et al (2018) Reducingpericyte-derivedscarringpromotesrecoveryafterspinal cordinjury. Cell 173:153.e22–165.e22
Diaz-Flores L, Gutierrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martin-Vasallo P, Díaz-Flores JL (2009) Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24:909–969
Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 5:355–363
Dore-Duffy P (2008) Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 16:1581–1593
Dore-Duffy P, Cleary K (2011) Morphology and properties of pericytes. Methods Mol Biol 686:49–68
Eberth CJ (1871) Handbuch der Lehre von der Gewegen des Menschen und der Tiere, vol 1. Engelmann, Leipzig
Enders G, Daiminger A, Bäder U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52:244–256
Engelhardt B (2003) Development of the blood-brain barrier. Cell Tissue Res 1:119–129
Farias KPRA, Moreli ML, Floriano VG, da Costa VG (2019) Evidence based on a meta-analysis of human cytomegalovirus infection in glioma. Arch Virol 164(5):1249–1257
Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO (2005) In vitro models for the blood–brain barrier. Toxicol In Vitro 19:299–334
Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ (2012) Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis 2012(206):1897–1903
Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J (2011) A pericyte origin of spinal cord scar tissue. Science 333:238–242
Hamilton NB, Attwell D, Hall CN (2010) Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenerg 2:1–14
Haspot F et al (2012) Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH independent and cholesterol-dependent manner. PLoS One 7:e34795
Heald-Sargent TA, Forte E, Liu X, Thorp EB, Abecassis MM, Zhang ZJ, Hummel MA (2020) New insights into the molecular mechanisms and immune control of cytomegalovirus reactivation. Transplantation 104:e118–e124. https://doi.org/10.1097/TP.0000000000003138
Hesp ZC, Yoseph RY, Suzuki R, Jukkola P, Wilson C, Nishiyama A et al (2018) Proliferating NG2-cell-dependent angiogenesis and scar formation alter axon growth and functional recovery after spinal cord injury in mice. J Neurosci 38:1366–1382
Huang ZR, Yu LP, Yang XC, Zhang F, Chen YR, Feng F, Qian XS, Cai J (2012) Human cytomegalovirus linked to stroke in a Chinese population. CNS Neurosci Ther 6:457–460
Janahi EMA, Das S, Bhattacharya SN, Haque S, Akhter N, Jawed A, Wahid M, Mandal RK, Lohani M, Areeshi MY, Ramachandran VG, Almalki S, Dar SA (2018) Cytomegalovirus aggravates the autoimmune phenomenon in systemic autoimmune diseases. Microb Pathog 120:132–139
Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 4:253–276
Kylat RI, Kelly EN, Ford-Jones EL (2006) Clinical findings and adverse outcomes in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatrics 165:773–778
Lai CH, Kuo KH (2005) The critical component to establish in vitro BBB model: Pericyte. Brain Res Brain Res Rev 2:258–265
Lee S, Brook E, Affandi J, Howson P, Tanudjaja SA, Dhaliwal S, Irish A, Price P (2019) A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population. Clin Transl Immunol 2:e1043
Lichtner M, Cicconi P, Vita S, Cozzi-Lepri A, Galli M, Lo Caputo S, Saracino A, De Luca A, Moioli M, Maggiolo F, Marchetti G, Vullo V, d’Arminio Monforte A, ICONA Foundation Study (2015) Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis 2:178–186
Liesz A (2019) The vascular side of Alzheimer’s disease. Science 6450:223–224
Lindahl P, Hellstrom M, Kalen M, Karlsson L, Pekny M, Pekna M, Soriano P, Betsholtz C (1998) Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125:3313–3322
Lövheim H, Olsson J, Weidung B, Johansson A, Eriksson S, Hallmans G, Elgh F (2018) Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer’s disease development. J Alzheimers Dis 3:939–945
Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 4:564–572
Lv YL, Han FF, Gong LL, Liu H, Ma J, Yu WY, Wan ZR, Jia YJ, Zhang W, Shi M, Liu LH (2017) Human cytomegalovirus infection and vascular disease risk: a meta-analysis. Virus Res 227:124–134
Martí-Carreras J, Maes P (2019) Human cytomegalovirus genomics and transcriptomics through the lens of next-generation sequencing: revision and future challenges. Virus Genes 2:138–164
Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL (2000) Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102:1917–1923
Nation DA, Ho JK, Dutt S, Han SD, MHC L (2019) Alzheimer’s disease neuroimaging initiative neuropsychological decline improves prediction of dementia beyond Alzheime’s disease biomarker and mild cognitive impairment diagnoses. J Alzheimers Dis 4:1171–1182
Nell S, Lurain BA, Hanson JM, Leurgans SE, Landay AL, Bennett DA, Schneider JA (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 4:564–572
Nigro G, Adler SP (2011) Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 23:123–128
Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, Kyrargyri V, Pfeiffer T, Khennouf L, Madry C, Gong H, Richard-Loendt A, Huang W, Saito T, Saido TC, Brandner S, Sethi H, Attwell D (2019) Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes. Science 19(6450):365
Pak CY, Eun HM, McArthur RG, Yoon JW (1988) Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 8601:1–4
Pass RF, Anderson B (2014) Mother-to-child transmission of cytomegalovirus and prevention of congenital infection. J Pediatr Infect Dis Soc Suppl 1:S2–S6
Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35:216–220
Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Gawronska-Szklarz B (2003) The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther 4:R210–R213
Popik W, Correa H, Khatua A, Aronoff DM, Alcendor DJ (2019) Mesangial cells, specialized renal pericytes and cytomegalovirus infectivity: implications for HCMV pathology in the glomerular vascular unit and post-transplant renal disease. J Transl Sci 2019:5
Price P, Eddy KS, Papadimitriou JM, Robertson TA, Shellam GR (1990) Cytomegalovirus infection of adipose tissues induces steatitis in adult mice. Int J Exp Pathol 4:557–571
Ramsauer M, Krause D, Dermietzel R (2002) Angiogenesis of the blood–brain barrier in vitro and the function of cerebral pericytes. FASEB J 16:1274–1276
Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ (2017) Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 6:e177–e188
Ribbert H (1904) Ueber protozoenartige Zellen in der Niere eines syphilitischen Neugeborenen und in der Parotis von Kindern. Zbl All Pathol 15:945–948
Rothe K, Quandt D, Schubert K, Rossol M, Klingner M, Jasinski-Bergner S, Scholz R, Seliger B, Pierer M, Baerwald C, Wagner U (2016) Latent cytomegalovirus infection in rheumatoid arthritis and increased frequencies of cytolytic LIR-1+CD8+ T cells. Arthritis Rheumatol 2:337–346
Rouget C (1873) Me’moire sur le de’veloppement, la structure et les propriete’s physiologiques des capillaires sanguins et lymphatiques. Arch Physiol Norm Path 5:603–663
Rowe WP, Hartley JW, Waterman S, Turner HC, Huebner RJ (1956) Cytopathogenic agents resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol 92:418–424
Rustenhoven J, Jansson D, Smyth LC, Dragunow M (2017) Brain pericytes as mediators of neuroinflammation. Trends Pharmacol Sci 3:291–304
Salmina AB, Komleva YK, Lopatina OL, Birbrair A (2019) Pericytes in Alzheimer’s disease: novel clues to cerebral amyloid angiopathy pathogenesis. Adv Exp Med Biol 1147:147–166
Schottstedt V, Blümel J, Burger R et al (2010) Human cytomegalovirus (HCMV)-revised. Transfus Med Hemother 2010(37):365–375
Shepro D, Morel NM (1993) Pericyte physiology. FASEB J 7:1031–1038
Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6:e16103
Sims DE (1986) The pericyte—a review. Tissue Cell 18:153–174
Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87(Pt 7):1763–1779
Smith MG (1956) Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med 92:424–430
Smith SW, Chand S, Savage CO (2012) Biology of the renal pericyte. Nephrol Dial Transplant 27:2149–2155
Smyth LCD, Rustenhoven J, Scotter EL, Schweder P, Faull RLM, Park TIH, Dragunow M (2018) Markers for human brain pericytes and smooth muscle cells. J Chem Neuroanat 92:48–60
Sochocka M, Zwolińska K, Leszek J (2017) The infectious etiology of Alzheimer’s disease. Curr Neuropharmacol 7:996–1009
Spyridopoulos I et al (2016) CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results fromthe Newcastle 85+ study. Aging Cell 15:389–392
Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford C (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 14:1904–1808
Stallcup WB (2018) The NG2 proteoglycan in pericyte biology. Adv Exp Med Biol 1109:5–19
Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285–293
Vancíková Z, Dvorák P (2001) Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review. Curr Drug Targets Immune Endocr Metabol Disord 2:179–187
Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 10:1144–1152
Wang C, Zhang X, Bialek S, Cannon MJ (2011) Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2:e11–e13
Weller TH, MacAuley JC, Craig JM, Wirth P (1957) Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Exp Biol Med 94:4–12
Wilkerson I, Laban J, Mitchell J, Sheibani N, Alcendor DJ (2015) Retinal pericytes and cytomegalovirus infectivity: Implications for both CMV induced retinopathy and congenital ocular disease. J Neuroinflamm 12:2
Yaiw KC, Mohammad AA, Costa H, Taher C, Badrnya S, Assinger A, Wilhelmi V, Ananthaseshan S, Estekizadeh A, Davoudi B, Ovchinnikova O, Shlyakhto E, Rafnsson A, Khan Z, Butler L, Rahbar A, Pernow J, Söderberg-Nauclér C (2015) Human cytomegalovirus up-regulates endothelin receptor type B: implication for vasculopathies? Open Forum Infect Dis 4:ofv155
Yamanaka N (1988) Development of the glomerular mesangium. Pediatr Nephrol 2:85–91
Yamazaki Y, Kanekiyo T (2017) Blood-brain barrier dysfunction and the pathogenesis of Alzheimer’s disease. Int J Mol Sci 18(9):E1965. pii: E1965
Yu X, Jih J, Jiang J, Zhou ZH (2017) Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150. Science 356:6345. pii: eaam6892
Zimmermann KW (1923) Der feinere Bau der Blutkapillaren. Z Anat Entwicklungsgesch 68:29–109
Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 12:723–738
Acknowledgements
The author would like to thank Waldemar Popik and Atanu Khatua for past collaborations.
Dedication
Special dedication to Dr. James E.K. Hildreth MD, PhD.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Funding: D.J.A. was supported by the Meharry Zika Startup Grant and a Research Centers in Minority Institutions (RCMI) program grant (U54MD007586-01).
Disclosure of Interests: All authors declare they have no conflict of interest.
Ethical approval: Studies involving humans.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was granted by the Institutional Review Boards (IRB) of Meharry Medical College, Johns Hopkins University Medical Center, and Vanderbilt University Medical Center. This includes all de-identified specimens from patients on slides.
Ethical approval: Studies involving animals.
This article does not contain any studies with animals performed by any of the authors.
Informed Consent: Informed consent for participation and publication was obtained from all individual participants included in the study.
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alcendor, D.J. (2021). Effects of Cytomegalovirus on Pericytes. In: Birbrair, A. (eds) Biology of Pericytes – Recent Advances. Stem Cell Biology and Regenerative Medicine, vol 68. Humana, Cham. https://doi.org/10.1007/978-3-030-62129-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-62129-2_4
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-62128-5
Online ISBN: 978-3-030-62129-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)